Clinical Trial: Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer

U.S., May 30 -- ClinicalTrials.gov registry received information related to the study (NCT07613151) titled 'Negative Hormone Receptor and APOcrine Lobular Invasive Breast Cancer' on May 19.

Brief Summary: The NAPOLI Study is a retrospective multicenter observational study designed to characterize negative hormone receptor and apocrine lobular invasive breast cancer. The study will collect real-world clinicopathological, molecular, therapeutic and outcome data from patients diagnosed and treated at participating centers. The aim is to describe the clinical behavior, pathological features, receptor profile, treatments received and oncologic outcomes of this rare breast cancer subtype.

Study Start Date: May 01

Study Type: OBSERVATIONAL

Con...